cholesterol drug will be in clinic later this year.
neuroprotective drug thereafter (unless early surprise).
statins are the biggest selling drugs in the world. something like 15b market.
and so far this drug appears to be a winner when compared to existing drugs in exactly the same pre clinical models.
exciting times ahead. lots and lots of upside.
limited downside at this entry of 40m market cap.
Ausbiotech studies in Australia are also probably relatively immune from CV19 interruptions. it's one of the best sectors probably.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.070(25.0%) |
Mkt cap ! $73.82M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 35.0¢ | 28.5¢ | $423.1K | 1.316M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 20970 | 2 |
View Market Depth
| Last trade - 16.17pm 21/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |